Harpoon Therapeutics, Inc. Common Stock
HARP
HARP was delisted on the 8th of March, 2024.
32 hedge funds and large institutions have $7.53M invested in Harpoon Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 14 closing their positions.
1.56% more ownership
Funds ownership: 44.84% → 46.4% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
27% less funds holding
Funds holding: 44 → 32 (-12)
37% less capital invested
Capital invested by funds: $12M → $7.53M (-$4.43M)
72% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 18
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$1.25M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$357K |
| 3 |
LPC
Lion Point Capital
New York
|
+$273K |
| 4 |
Renaissance Technologies
New York
|
+$25.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.5K |
| 2 |
State Street
Boston,
Massachusetts
|
-$60.5K |
| 3 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
-$45.4K |
| 4 |
Millennium Management
New York
|
-$44.1K |
| 5 |
Two Sigma Investments
New York
|
-$30.6K |
HARP Hedge Fund Activity: Q3 2023 in Review
32 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q3 2023, worth a combined $7.53M — down 37% from $12M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HARP and 3 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 5 added.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $1.25M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $62.5K sold.
- 32 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q3 2023, down from 44 in Q2 2023.
- Funds reported $7.53M of Harpoon Therapeutics, Inc. Common Stock stock for Q3 2023, down 37% quarter-over-quarter.
- 3 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q3 2023 and 14 closed out, a net change of -11 holders.
- The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q3 2023 was Sio Capital Management, an estimated $1.25M added.
- The largest Harpoon Therapeutics, Inc. Common Stock seller in Q3 2023 was Bridgeway Capital Management, an estimated $62.5K sold.
Based on aggregated 13F filings for Q3 2023.